Lipoproteins are classified based on their density, particle size and electrophoretic mobility \[[@r21]\]. In human medicine, many detection methods have been developed for lipoprotein profiling. Conventionally, density gradient ultracentrifugation (DGUC) has been the most widely used procedure for lipoprotein fractionation \[[@r11]\], but this method is difficult to apply in clinical tests because it is a time-consuming and complicated procedure requiring a large sample volume \[[@r21]\]. Polyacrylamide or agarose gel electrophoresis-based methods have also been described and clinically applied for human applications \[[@r18], [@r21]\]. However, because animal lipoproteins are not well characterized and their compositions are different from those of humans, it is often difficult to separate animal lipoproteins using conventional electrophoresis procedures developed for humans. We previously reported the use of a simple and high-quality method for detecting a canine lipoprotein profile using a high-performance liquid chromatography system with gel permeation columns (GP-HPLC) and on-line dual enzymatic detection, which was originally described by Usui *et al.* \[[@r21]\]. The aim of the present study was to confirm the feasibility of this method for obtaining the lipoprotein profile of cats. These data should also help to provide a standardized lipoprotein profile of healthy cats.

MATERIALS AND METHODS {#s1}
=====================

To compare the lipoprotein profiles obtained using the DGUC and GP-HPLC methods, blood samples were obtained from three healthy Japanese domestic cats (4 years old, male and body weight approximately 4 kg) that were maintained in our laboratory at the Nippon Veterinary and Animal Science University. Blood samples for determination of standard lipoprotein profiles of cats were obtained from 20 healthy Japanese domestic cats (11 males; 5.9 ± 4.2 years and 9 females: 5.5 ± 4.5 years) that were brought to the Okuda Animal Hospital for standard health examinations. Clinical observations and general blood examination (complete blood counts and biochemical analysis conducted by the Yokohama Laboratory of Lance Ltd. (Yokohama, Japan) revealed no abnormalities in any of the cats. Blood samples were collected from the jugular vein after fasting for more than 10 hr and before feeding in the morning. Plasma samples treated with EDTA were isolated by centrifugation at 1,800 × *g* for 10 min. DGUC was performed immediately after plasma separation, whereas other analyses were carried out within 3 days of sample collection and the samples were stored at 4°C.

The dual-detection GP-HPLC method for lipoprotein profile analysis was described previously \[[@r16], [@r18], [@r21]\]. This analysis was performed by Skylite Biotech Corporation in their laboratory (Akita, Japan). The DGUC method and agarose gel electrophoresis were performed as previously described for dogs \[[@r16]\] using commercial kits (Titan III gel system with an Fat Red 7B staining kit; Helena Laboratories; Saitama, Japan and Calibrated Densitometer GS-800; Bio-Rad Laboratories; Hercules, CA, U.S.A.).

Statistical analysis for comparison between sexes was carried out by the Student's *t*-test using the StatView program (version 5.0, Japanese Edition; SAS Institute Inc., Cary, NC, U.S.A.). Data are presented as mean ± SD.

RESULTS {#s2}
=======

The lipid profiles of the whole plasma of Cat 1 as determined by GP-HPLC and DGUC are shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.The results of lipoprotein analyses in Cat 1 (4-year-old male, healthy Japanese domestic cat). The lipoprotein profiles of whole plasma acquired by (A) high-performance liquid chromatography with gel permeation columns (GP-HPLC) and (B) density gradient ultracentrifugation (DGUC). (C and D) GP-HPLC pattern of the high-density lipoprotein (HDL) fraction (Fraction \#8) and the low-density lipoprotein (LDL) fraction (Fraction \#14) separated by the DGUC method. (E) Agarose gel electrophoretic patterns of whole plasma (WP) and several fractions (\#2, 5, 8, 12, 14, 20, 26 and 27).A and 1-B, respectively. As shown in Figure, the cholesterol curves obtained from both analytical methods provided two peaks, one large peak and one small peak. Fraction \#8 of [Fig. 1](#fig_001){ref-type="fig"}B was analyzed by GP-HPLC, and a single peak was eluted at 28--29 min ([Fig. 1](#fig_001){ref-type="fig"}C). Fraction \#14 showed a small peak eluted at around 24 min and smaller peak at around 28 min by GP-HPLC ([Fig. 1](#fig_001){ref-type="fig"}D). The result of agarose gel electrophoresis from the Cat1 sample is shown in [Fig. 1](#fig_001){ref-type="fig"}E, which presents the electrophoretic patterns of the whole plasma and the DGUC fractions (\#2, 5, 8, 12, 14, 20, 26 and 27). Fractions \#2, 5 and 8, which correspond to the larger peak, produced a single band at the position corresponding to α-lipoprotein (HDL), and Fractions \#12 and 14, which produced a smaller peak, showed two bands at the α-and β-lipoprotein (LDL) positions. However, any band was not obtained from fraction \#20. Fractions \#26 and 27 produced a broad band from the application point (chylomicron \[CM\]) to the pre-β (very low-density lipoprotein \[VLDL\]) position. Therefore, the larger fraction that peaked at around 28--29 min by GC-HPLC=was identified as HDL. The smaller peak at 24--25 min was also observed in this investigation. As shown in [Table 1](#tbl_001){ref-type="table"}Table 1.Concentrations of lipids in each lipoprotein fraction as analyzed by DGUC and GP-HPLC in healthy catsItemUnitGP-HPLCDGUCCat 1Cat 2Cat 3Cat 1Cat 2Cat 3HDLT-chomg/d*l*138.1119.895.3117.5123.896.7TGmg/d*l*4.73.52.80.51.21.4PLmg/d*l*344.0308.5245.6303.9312.4243.6LDLT-chomg/d*l*34.824.016.730.314.011.9TGmg/d*l*10.28.912.33.93.06.0PLmg/d*l*41.430.925.841.117.822.4VLDLT-chomg/d*l*3.83.53.0TGmg/d*l*21.114.327.0PLmg/d*l*5.35.75.6CMT-chomg/d*l*0.60.10.2TGmg/d*l*14.02.26.0PLmg/d*l*1.10.20.0VLDL+CMT-chomg/d*l*6.35.13.0TGmg/d*l*114.728.965.4PLmg/d*l*18.710.715.9TotalT-chomg/d*l*177.4147.5115.2169.1142.9112.6TGIFmg/d*l*50.028.949.1119.633.272.7PLmg/d*l*391.7345.3277.0341.0341.0281.9HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein; CM: chylomicron. T-cho: total cholesterol; TG: triglyceride; PL: phospholipids. GP-HPLC: high-performance liquid chromatography with gel permeation columns. DGUC: density gradient ultracentrifugation., the concentrations of lipids in whole plasma as determined by DGUC and GP-HPLC were compared with those in each lipoprotein fraction analyzed ([Table 1](#tbl_001){ref-type="table"}). As shown in Table, the little difference was observed in cholesterol levels estimated with the DGCU and GP-HPLC method. In contrast, larger differences were observed with respect to the TG level of each fraction. The larger difference was especially true in the VLDL+CM fraction.

The lipid concentrations in each lipoprotein and the particle sizes determined by GP-HPLC of the 20 healthy cats are shown in [Tables 2](#tbl_002){ref-type="table"} and[3](#tbl_003){ref-type="table"}Table 2.Comparison of lipoprotein profiles between male (n=9) and female (n=11) healthy cats. Data are mean ± SD. *P*-values were calculated by the Student's *t*-test (male vs. female)LipoproteinItemUnitMales (n=9)Females (n=11)*P*-valueTotal (n=20)\*HDLT-chomg/d*l*130.4 ± 47.6125.1 ± 19.70.737128 ± 35TGmg/d*l*4.6 ± 3.94.4 ± 1.90.884.6 ± 2.9LDLT-chomg/d*l*26.9 ± 25.117.4 ± 8.30.25122.54 ± 18.1TGmg/d*l*13.3 ± 5.913.5 ± 4.70.92713.4 ± 5VLDLT-chomg/d*l*2.8 ± 1.62.2 ± 1.20.3472.4 ± 1.4TGmg/d*l*29.8 ± 2619.3 ± 12.60.25123.4 ± 19.6CMT-chomg/d*l*0.1 ± 0.10.1 ± 0.30.5020.1 ± 0.2TGmg/d*l*5.7 ± 11.62.7 ± 3.60.4173.9 ± 7.9TotalT-chomg/d*l*160.3 ± 68.2144.7 ± 26.30.494153.2 ± 49.7TGmg/d*l*53.3 ± 44.339.8 ± 17.40.36445.6 ± 33HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein;CM: chylomicron; T-cho: total cholesterol; TG: triglyceride.Table 3.Comparison of lipoprotein particle sizes between male and female healthy cats. Data are mean ± SD. *P*-values were calculated by the Student's *t*-test (male vs. female)Lipoprotein UnitMale (n)Female (n)*P*-valueTotal (n)HDLnm11.4 ± 0.5 (9)11.1 ± 0.3 (11)0.16411.2 ± 0.4 (20)LDLnm22.8 ± 0.6 (8)21.8 ± 0.8 (10)0.01522.3 ± 0.9 (19)VLDLnm40.2 ± 1.4 (8)40 ± 2.5 (11)0.7892.2 (19)HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein., respectively. There was no difference in lipoprotein profiles between males and females, but males had a significantly larger LDL particle size (*P*=0.015).

DISCUSSION {#s3}
==========

The cholesterol curves obtained from both analytical methods, GP-HPLC and DGUC, provided two peaks, one large peak and one small peak, which was a similar pattern to that observed in dogs in our previous study \[[@r16]\]. Fraction \#8 with a larger peak corresponding to the high-density lipoprotein (HDL) fraction according to previous reports \[[@r1], [@r15], [@r22]\], was analyzed by GP-HPLC, and a single peak was eluted at 28--29 min. Fraction \#14, which comprised the low-density lipoprotein (LDL) fraction, showed a small peak eluted at around 24 min and smaller peak at around 28 min by GP-HPLC. Usui *et al.* \[[@r21]\] also reported the outflow of endogenous free glycerol after HDL elution. The peak observed at around 36 min in GP-HPLC whole plasma analysis was considered to be free glycerin.

We considered the smaller peak at 24--25 min to be LDL. However, when the LDL fraction separated by DGUC was analyzed using the GP-HPLC method, it was partially included in the small and cholesterol-rich lipoprotein component. Agarose gel electrophoresis revealed 2 bands for this LDL fraction, at the β and α positions. These observations indicated that it is impossible to accurately separate the cat LDL by DGUC. The small particles, which showed the specific gravity of LDL, were considered to be apolipoprotein E-rich HDL (ApoE-rich HDL) or small, dense LDL (sdLDL). The gravity of sdLDL is the same as that of normal LDL, but the particle size is smaller; this lipoprotein fraction is closely related to metabolic syndrome in humans \[[@r6],[@r7], [@r17], [@r20]\]. On the other hand, ApoE-rich HDL, which consists of cholesterol-rich particles with a low-gravity HDL and is observed in cholesterol ester transfer protein (CETP)-deficient patients \[[@r3], [@r23]\], was electrophoresed into α-lipoprotein on the agarose gel. Because cats have low CETP activity \[[@r10]\], this result suggests that ApoE-rich HDL is also observed in healthy cats. In this study, we could not determine whether this fraction was sdLDL or ApoE-rich HDL; nonetheless, the results suggest that healthy cats have a small amount of cholesterol-rich particles that are distinct from normal LDL or HDL.

Because our DGUC method could not accurately separate CM and VLDL in cats, it was not possible to confirm their elution times by the GP-HPLC method using DGUC-separated fraction samples. However, the gradual triglyceride (TG) peak observed near the 22-min mark in whole plasma analyzed with GP-HPLC method was considered to be derived from VLDL particles based on particle size. In addition, the TG peak produced at around 18 min was considered to correspond to CM.

Little difference was observed in cholesterol and TG levels estimated with the DGUC and GP-HPLC methods. Using the DGUC method, the TG-rich lipoprotein fraction was previously reported to adhere to the wall of the centrifugation tube, which could lead to quantification errors \[[@r21]\]. The large variability in the VLDL+CM fraction between DGUC and GP-HPLC was likely caused by the large particle size of the cat's CM, which is greater than the maximum particle size that can pass through the GP-HPLC column. Therefore, it would be useful to confirm whether there is any deviation between the values obtained for total plasma TG levels as measured by GP-HPLC and an enzymatic assay method for general blood biochemistry to accurately evaluate the TG-rich lipoprotein profile with the GP-HPLC method.

There was no difference between lipoprotein profiles of males and that of females, but lipoprotein profiles of males had a significantly larger LDL particle size (*P*=0.015). Gender differences of LDL particle size have been reported in human \[[@r2], [@r19]\]. It was reported that serum triglyceride concentration \[[@r2], [@r4], [@r13], [@r19]\], insulin resistance \[[@r4], [@r13]\] and proinsulin concentration \[[@r4]\] affect average LDL particle size. While gender differences of these factors are considered to lead to gender differences of LDL particle size. In the present study, we did not verify these factors. This problem will be future challenges. The results indicate that the healthy cats' lipoprotein profile could be characterized as an HDL-rich profile, i.e., high HDL, low LDL, and marginal VLDL and CM contents were detected. This pattern is similar to that of healthy dogs reported previously \[[@r16]\], although the cat's LDL had a lower TG content compared to that of dogs.

Development of hyperlipidemia is often related to endocrine disease. Human type 2 diabetes mellitus patients often present hyperlipidemia \[[@r8], [@r14]\], and we previously reported that diabetic dogs had high concentrations of VLDL-TG and VLDL-cholesterol \[[@r16]\]. Similar to dogs and humans, many of the lipid metabolism abnormalities observed in cats are caused by endocrine diseases, such as diabetes \[[@r5]\]. Furthermore, congenital anomalies with hyperlipidemia, such as LPL deficiency \[[@r9], [@r12]\], have also been reported in cats. Collectively, our results show that the GP-HPLC method can produce accurate lipoprotein profiles using a small sample volume and thus shows good potential for research and diagnosis of dyslipidemia in cats.
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